Profile of Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir in the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s80226
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Safety of Ombitasvir/Paritaprevir/Ritonavir+dasabuvir in Chronic Hepatitis C Patients With HCV Genotype 1 Infection

Acta Poloniae Pharmaceutica
PharmacologyPharmaceutical Science
2019English

A Real-Life Data on the Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir +Ribavirin in Patients With Genotype 1 Chronic Hepatitis C Virus Infection in Serbia

Vojnosanitetski Pregled
MedicinePharmacology
2019English

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for Chronic HCV Infection in US Veterans With Psychiatric Disorders

Journal of Medical Virology
VirologyInfectious Diseases
2020English

Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin in Treatment of Chronic Hepatitis C Patients With End Stage Renal Disease on Regular Hemodialysis

International Journal of Medical Arts
2020English

Drug-Drug Interactions Between Sofosbuvir and Ombitasvir-Paritaprevir-Ritonavir With or Without Dasabuvir

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2015English

Real-World Experience With Ombitasvir/Paritaprevir Boosted With Ritonavir and Possibly Combined With Dasabuvir and Ribavirin in HCV Infection

Clinical and Experimental Hepatology
Hepatology
2016English

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis-C Virus Infection in Venezuela

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Boceprevir in the Treatment of Chronic Hepatitis C Virus Infection

Virus Adaptation and Treatment
VirologyInfectious DiseasesImmunology
2011English

Gender Influence on Treatment of Chronic Hepatitis C Genotype 1

Revista da Sociedade Brasileira de Medicina Tropical
ParasitologyInfectious DiseasesMicrobiology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy